Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rau

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Clinical Epigenetics|September 28, 2018
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathwayJanina Graule, Kristin Uth, Elia Fischer, et al.
Dysphagia|March 7, 1998
Comparing treatment intensities of tactile-thermal applicationJ C Rosenbek, J Robbins, W O Willford, et al.
The Journal of Clinical Investigation|October 11, 2016
Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinomaElisabeth Naschberger, Andrea Liebl, Vera S Schellerer, et al.
The American Journal of Pathology|February 27, 2013
Death-associated protein kinase controls STAT3 activity in intestinal epithelial cellsSaritha Chakilam, Muktheshwar Gandesiri, Tilman T Rau, et al.
Virchows Archiv : an International Journal of Pathology|December 19, 2023
Swiss digital pathology recommendations: results from a Delphi process conducted by the Swiss Digital Pathology Consortium of the Swiss Society of PathologyAndrew Janowczyk, Inti Zlobec, Cedric Walker, et al.
The Journal of Pathology|December 13, 2019
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomasAlicia León-Castillo, Ester Gilvazquez, Remi Nout, et al.
Nature Medicine|February 25, 2014
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's diseaseRaja Atreya, Helmut Neumann, Clemens Neufert, et al.
Human Molecular Genetics|November 1, 2016
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion statusManuel Luedeke, Antje E Rinckleb, Liesel M FitzGerald, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2022
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional studyBalazs Acs, Samuel C Y Leung, Kelley M Kidwell, et al.
Nature Communications|October 8, 2025
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancerGesa Mittmann, Sara Laiouar-Pedari, Hendrik A Mehrtens, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Clinical Epigenetics|September 28, 2018
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathwayJanina Graule, Kristin Uth, Elia Fischer, et al.
Dysphagia|March 7, 1998
Comparing treatment intensities of tactile-thermal applicationJ C Rosenbek, J Robbins, W O Willford, et al.
The Journal of Clinical Investigation|October 11, 2016
Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinomaElisabeth Naschberger, Andrea Liebl, Vera S Schellerer, et al.
The American Journal of Pathology|February 27, 2013
Death-associated protein kinase controls STAT3 activity in intestinal epithelial cellsSaritha Chakilam, Muktheshwar Gandesiri, Tilman T Rau, et al.
Virchows Archiv : an International Journal of Pathology|December 19, 2023
Swiss digital pathology recommendations: results from a Delphi process conducted by the Swiss Digital Pathology Consortium of the Swiss Society of PathologyAndrew Janowczyk, Inti Zlobec, Cedric Walker, et al.
The Journal of Pathology|December 13, 2019
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomasAlicia León-Castillo, Ester Gilvazquez, Remi Nout, et al.
Nature Medicine|February 25, 2014
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's diseaseRaja Atreya, Helmut Neumann, Clemens Neufert, et al.
Human Molecular Genetics|November 1, 2016
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion statusManuel Luedeke, Antje E Rinckleb, Liesel M FitzGerald, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2022
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional studyBalazs Acs, Samuel C Y Leung, Kelley M Kidwell, et al.
Nature Communications|October 8, 2025
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancerGesa Mittmann, Sara Laiouar-Pedari, Hendrik A Mehrtens, et al.
Pageof 14